Meta-analysis - Eltrombopag

• Status: Completed
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the meta-analysis was to explore the efficacy of eltrombopag versus placebo (standard of care)

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion Criteria:

• Adults with ITP

• Received a pre-specified treatment

• Prospective clinical studies with at least 10 patients

Exclusion Criteria:

• Subjects with ITP due to other causes